SHANGHAI, April 12, 2022 /PRNewswire/ – Forbes
released the 2022 Midas List on April 12, a
ranking of the world's top 100 venture capitalists. Nisa Leung, Managing Partner of Qiming Venture
Partners, and Duane Kuang, Founding
Managing Partner of Qiming Venture Partners, ranked on the
list.
Since 2001, Forbes announces its annual Midas List of the
top VC investors in the world. The name is an allusion to
Greek mythology where King Midas is renowned for his ability
to turn everything he touched into gold.
Nisa has been on the list for four consecutive years, ranking
No.61 and up 12 places from last
year. In the past three years, Nisa was ranked as No.1 healthcare
investor in China and she has also
been consistently ranked as one of Forbes
China's best female venture capitalists, topping the list
for the first time in 2022.
Nisa and her team invest with a desire to improve China's
healthcare environment and address unmet healthcare needs for the
people's betterment. As one of the earliest investors in the
sector, Nisa and her team invested in over 170 healthcare
companies, including Zai Lab
(NASDAQ:ZLAB, SEHK:9688), CanSino Biologics (SEHK:6185,
SHSE:688185), Gan & Lee Pharmaceuticals (SHSE:603087), New
Horizon Health (SEHK:6606), Venus MedTech (SEHK:2500), and
Schrödinger (NASDAQ:SDGR) for the past decade.
For the past fifteen months, thirteen of Qiming's healthcare
companies completed public offerings. Notable exits include New
Horizon Health and Sino Biological.
Nisa believes that China healthcare companies will increasingly
develop global footprint in the future. As a trailblazer and leader
in the healthcare investment, Qiming Venture Partners works closely
with its entrepreneurs and looks for outstanding companies in the
fields of innovative drug research and development, devices,
diagnostics, services and digital health, and continues to work
towards high-quality development of China's healthcare
industry.
Duane has been named on the Midas list for the third time,
ranking No.74 this year. Duane
co-founded Qiming Venture Partners in 2006 and has been leading the
TMT team.
As Founding Managing Partner of Qiming Venture Partners, Duane
has over 30 years of corporate management and investment
experience, and has been active in the front line of the venture
capital field. His portfolio includes star companies such as
Xiaomi, RoboRock, Unisound, Qiniu, UBTech, Hesai Technology
and WeRide. The technology sector covering artificial intelligence,
enterprise services, semiconductors, blockchain and other fields
has been a focus of Qiming Venture Partners for 15 years.
Today, Qiming Venture Partners is recognized as one of the most
professional investment institutions in the field of AI,
semiconductors and SaaS. Building presence in the "hardcore
technology" field in 2021, Duane and his team have invested in many
high-growth enterprises equipped with cutting-edge
technologies.
At present, China's investment and innovation environment is
undergoing tremendous changes. Duane believes that the key factor
in innovation is the development of science and technology and that
China's new economy is blazing a different innovation trail from
the past; the new generation of entrepreneurs has stronger
capabilities to innovate in technology, and products are becoming
more and more internationally competitive. Qiming Venture Partners
upholds the belief of being entrepreneur-friendly and provides more
systematic services to its portfolio companies.
Currently Qiming Venture Partners manages ten US Dollar funds and six RMB funds with $6.2
billion assets under management. Qiming invests in
outstanding companies in the TMT and healthcare sectors at the
early and growth stages. In 2021, Qiming closed over 70 deals; 13
portfolio companies completed public offerings, and over 100
companies raised new financing rounds.
While achieving outstanding investment performance and being
widely recognized by LPs around the world, Qiming is also proactive
in practicing social responsibility. In 2021, Qiming partnered
with China Foundation for Poverty Alleviation to launch a
new initiative dedicated to empowering rural entrepreneurs with a
donation of CNY 100 million, so as to
contribute to China's rural revitalization.
Qiming Venture Partners believes in ESG and will continue to
identify companies which can play an essential role in economic and
social development. The company will also facilitate cutting-edge
technologies and promote the transformation of scientific research
through ecosystem construction and resource integration, so as to
improve efficiency and enhance human well-being.
About Qiming Venture Partners
Founded in 2006, Qiming Venture Partners is a leading China
venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston and the San
Francisco Bay Area.
Currently, Qiming Venture Partners manages ten US Dollar funds and six RMB funds with $6.2
billion in AUM capital raised. Since our establishment, we
have invested in outstanding companies in the TMT and healthcare
industries at the early and growth stages.
Since our debut, we have backed over 430 fast-growing and
innovative companies. Over 170 companies are already listed on
NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock
Exchange and Shenzhen Stock Exchange, or achieved exit through
M&A and other means. There are also over 40 portfolio companies
that have achieved unicorn status.
Many of our portfolio companies are today's most influential
firms in their respective sectors, including Xiaomi (SEHK:1810),
Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Zhihu
(NYSE: ZH), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals
(SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), CanSino
Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT
Medical (SHSE:688617), New Horizon Health (SEHK:6606), Venus
MedTech (SEHK:2500), Sanyou Medical (SHSE:688085), AmoyDx
(SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE:
688520), Yuanxin Technology, and UBTech among many others.
View original
content:https://www.prnewswire.com/news-releases/qimings-nisa-leung-duane-kuang-named-on-2022-forbes-midas-list-301524461.html
SOURCE Qiming Venture Partners